looming breakout. , page-9

BOT,

one thing i do know is that it's only going to take one sniff of revenue flowing and the diagnostic business plan working and this will be off to the races.

management have spruiked the resmed analogy for a reason -- its the same strategy. only difference is that asthma is already recognised as a huge problem. sleep apnea was not so resmed took ages to take off.

the sell side is very thin, although you never know who is lurking off stage. i think what will become more apparent is that the new board will have supporters in the US coming to the party. deeper pockets will help drive this to where it should be in coming months. i dont expect management to front the annual meeting without a nice little surge in the shareprice. that means 3 weeks to get this cracking and ensure a room full of happy shareholders for the first dance.